 ÏÊ»¨( 219)  ¼¦µ°( 0)
|
% H8 x1 D$ _- P" ~& I- s3 }0 b
( y# z# H, W) a
; e9 p Z, N4 c´ó¼ÒºÃ£¬
) `. h% \2 S+ p0 D, j2 c, H
: r7 W* Z0 w0 |2 w* M' A/ U, g»¶Ó¹âÁÙ½¡¿µÓªÑøÕ¾É̳ǡ£ÎÒÊǽ¡¿µÓªÑøÕ¾µÄ°æÖ÷¡£ÎÒ±ÏÒµÓÚU Of A ÓªÑøÏµ¡£Ä¿Ç°¾ÓªÓªÑø²úÆ·¡£ÎÒËù¾ÓªµÄÓªÑø²úÆ·±£Öʱ£Á¿¡£¶øÇÒÔÚͬÑùµÄÆ·ÅÆÀÎÒ±£Ö¤¼ÛÇ®×îµÍ¡£ ¿µ¼ÓÃÀ²úÆ·ÊÇÎÒĿǰ¾ÓªµÄÖ÷Òª²úÆ·Ö®Ò»¡£ÎªÁËÄúµÄ·½±ã£¬ËùÓвúÆ·µÄÏêϸÇé¿öºÍ¼ÛÇ®¿ÉÒÔµã»÷ÕâÀïÕÒµ½ - C' T& \: P6 ^" K- L! J" h
[url]http://www.edmontonchina.ca/forumdisplay.php?fid=91
$ Y. ]% |, T& [, K, {2 w c# \5 E. f
¶©¹º×Éѯ£º£¨780£©669-6586²úÆ·  780-249-1365' R$ o) C% u! z: g9 s$ X
Email£º c.health@hotmail.com
3 h- a+ z0 A, F+ a8 I
6 @# I& P4 {! I) v: }$ ^6 n¿µ¼ÓÃÀ²úÆ·¼ò½é£º
8 t2 b$ U/ z* {- O" ~% ?& w0 F
; s- l3 W; G- \9 S& l7 I: ` n¼ÓÃÀ¿ÆÑÐÖÆÒ©ÓÐÏÞ¹«Ë¾Î»ì¶×ÔÈ»×ÊÔ´·á¸»µÄ¼ÓÄô󰲴óÂÔÊ¡£¬Ç±ÐÄÑÐÖÆÌìȻҩÁƽ¡¿µ®bÆ·¡£ÎÒÃǵÄ×î´óÐÄÔ¸Êǽ«ÓÅÖÊÌìȻֲÎï»òº£ÑóÉúÎᆱ»ª£¬½áºÏ×ÔÈ»Éú»îµÄ½¡¿µÀíÄîÍÆ½é¸øËùÓмÒÍ¥£¬ ÁîÄãºÍ¼ÒÈËÊܵ½´¿×ÔÈ»µÄ±£»¤£¬×à³öÇáËɽ¡¿µÔÏÀÖ¡£
+ R6 L4 q$ p: d$ B1 ?2 o* s6 u, Z3 w. a# S9 j- c+ r$ U
¼ÓÃÀ¿ÆÑÐÖÆÒ©ÊǼÓÄôó±¾ÍÁ¾ß¹æÄ£ºÍʵÁ¦µÄÖÆÒ©¹«Ë¾¡£ÎÒÃǵÄÖ÷ÒªÒµÎñ°üÀ¨ÓÅÖʱ£½¡Æ·µÄÉú®b¡¢ÁãÊÛ¡¢Åú·¢£¬¸ü ‘´Óʸ߼¶±£½¡Æ·Éú®bµÄ³§¼ÒºÍ¸öÈËÌṩ¿É¿¿ÖÜÈ«µÄ¼Ó¹¤·þÎñ (OEM)¡£×Ô³ÉÁ¢ÒÁʼ£¬¼ÓÃÀ¿ÆÑÐ ²»¶ÏͶ·Å´óÁ¿×ÊÔ´Ñо¿ÌìÈ»½¡¿µÆ·¡£Ê®¶àÄêǰÒѳɹ¦½«ÌìÈ»º£±ªÓÍ¡¢ÉÈýÎÄÓãÓÍÔÓÍת»¯Îª¶àÖÖ±£½¡¹¦Ð§£¬ÈÝÒ×ÎüÊյĽ¡¿µ®bÆ·¡£ÆäUNCLE BILL Æ·ÅÆµÄÌìÈ»º£±ªÓÍ£¬ÉÓãÓÍ£¬ÂÑÁ×Ö¬µÈÌìÈ»®bÆ·Ê®¶àÄêÀ´Ò»Ö±±¸ÊÜÏû·ÑÕßÐÅÀµ£¬ÊÇ´ó¼Ò×ÔÓúÍÀ¡ÔùÇ×ÓѵÄÊ×Ñ¡ºÍÖ¸¶¨®bÆ·¡£2 p; F N) [& C9 z
) X+ \- i b9 B7 |, D, A3 H! @
¶þÊ®ÔØ ¾Óª£¬ ¶þÊ®ÔØ³ÏÐÅ£¬ Ò»Èç¼ÈÍù. ¸ß¿Æ¼¼Í¶ÈëºÍ³¤¾QͶ×ʳɾÍÁ˼ÓÃÀ¿ÆÑÐÖÆÒ© ÔÚ½¡¿µ®bÆ·Òµ½çµÄÇ̳þµØÎ»£¬ÊµÁ¦²»ÈÝÖÃÒÉ¡£Ê±ÖÁ½ñÈÕ, ¼ÓÃÀ¿ÆÑÐÒÑ·¢Õ¹ ‘Ò»¼äÓÐʵÁ¦ºÍ¹æÄ£µÄÖÆÒ©¹«Ë¾¡£¼ÓÃÀµÄ¼¼ÊõÍÅÒ²ÈÕÒæ×³´ó£¬³ýÍøÂÞ±¾µØÒ½Ò©Ïµ¾«Ó¢Í⣬¸üÖØ½ðͶ×ÊÉ豸¾«Á¼µÄÒ©Æ·¼ìÑéʵÑéÊÒ£¬ ¶ÔÿÅú®bÆ·½øÐÐ Standard Operation Procedure (SOP)¼ì²â£¬½¨Á¢ÖÊÁ¿×·×Ù»ØÊÕϵͳ£¬ ¾ø¶Ô·ûºÏ¼ÓÄôóÎÀÉú²¿Ò©Îï¼à¹ÜÒªÇó, Æ·ÖÊ ‘Òµ½çÖ®¹Ú¡£
" W& j. t C, K) q/ L
& o$ R: a" L# I' [- G5 {6 A# d* O¼ÓÃÀ¿ÆÑÐÖÆÒ©´´Á¢ºÇ»¤ÉíÐĵġ°¿µ¼ÓÃÀ¡±£¬¡°±êÊ塱һϵÁб£½¡¾«Æ·£¬ ÁÆÐ§ÏÔÖø£¬ÉîÊÜÓüÒÐÅÀµ¡£¼ÓÃÀ¿ÆÑÐÊôÏÂËùÓЮbÆ·¾ùÒÑÉ걨¼ÓÄôóÎÀÉú²¿£¬ÊÇ×îÖµµÃÐÅÀµµÄÌìÈ»±£½¡Æ·Éú®b³§¼Ò¡¢ÖøÃû½¡¿µ®bÆ·¶À¼Ò´úÀíºÍÅú·¢ÉÌ¡£
$ V2 E6 p- D" c7 s3 s2 O7 B
0 k: P. \% m/ [, n¼ÓÃÀ¿ÆÑÐÉèÓжàÌõÏȽøµÄÉú®bÏߣ¬´ÓÖÆÔìµ½°ü×°¸÷ÖÖÉú®b³ÌÐò£¬¾ùÓɵçÄÔ¿ØÖÆ£¬²¢ÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬¶ÔËùÓвÄÖʼ°ÖÆ³ÉÆ·½øÐÐÑϸñ²âÊÔ£¬·¢»Ó¿ÆÑ§¹ÜÀíµÄ³¬×¿Ð§ÄÜ¡£¼ÓÃÀµÄרҵÍŶӼá³ÖÒÔÆ·ÖÊΪ±¾£¬Á¦ÕéÍêÃÀ£¬²»¶ÏÇó½øºÍ´´Ð¡£ $ F3 w0 ~4 ~- q" n( l- |9 o
" s. F9 O$ W$ v {¼ÓÃÀ¿ÆÑÐÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬ ÎÒÃǵÄרҵ¼¼ÊõÔ±¶Ô¸÷ÖÖÔÁϺÍÖÆ³ÉÆ·½øÐзÖÎö£¬ È·±£ÔÁϸßЧÐÔ£¬²¢Ñϸñ²âÊÔÿÅú²úÆ·µÄÖÊÁ¿ºÍ°²È«ÐÔ¡£¼ÓÃÀ¿ÆÑÐÖÆÒ©Ëù²ÉÓÃÔ²ÄÁÏ£¬ ÖÆÔì¹ý³ÌºÍ³ÉÖÊÁ¿¾ù·ûºÏ«ÃÀ¹úÒ©µä» * (US Pharmacopoeia (USP))±ê×¼£¬²¿·ÖÔÁϺͮbÆ·ÉõÖÁ³¬¹ý´Ë±ê×¼¡£ 9 d; e/ S6 G4 Y( D t
! F4 N, t ] [; G; i- J( `* k¼ÓÃÀ¿ÆÑÐÖÆÒ©µÄרҵ¾«Ó¢ÓÐÀ´×Ô±±ÃÀÖøÃû´óѧҽҩϵµÄ˶ʿºÍ ²©Ê¿£¬ ¼ÈÓÐÀ´×ÔÖйúÌìȻҩÎïÓë·ÂÉúÒ©Îï¹ú¼ÒÖØµãʵÑéÊÒ£¬»¹Óб±ÃÀÖÆÒ©ÐÐÒµ¾Ñé·á¸»µÄ¼¼Ê¦¡£ËûÃǶÔÌìÈ»®bÆ·µÄ¹¦Ð§ºÍÒ©ÀíÌØÐÔÓÐÉîÇÐÁ˽⡣¼ÓÃÀ¿ÆÑÐÖÆÒ©ÒѲ¼À³¿Ë´óѧ£¬ POLECNECTARÂ̷佺¹«Ë¾µÈ½øÐпÆÑкÏ×÷£¬²»¶Ï¸ÄÁ¼Ñз¢²úÆ·£¬ÎñÇó¸øÓè¹Ë¿Í×î¼ÑÆ·ÖÊ¡£, n, H5 S2 h* r3 c/ F
6 Z* d7 D- o! J( Z2 @, m
[ ±¾Ìû×îºóÓÉ ½¡¿µÓªÑøÕ¾ ÓÚ 2008-11-17 12:54 ±à¼ ]7 M, m ] K+ B1 R/ r, N
gmp.gif (9.82 KB, ÏÂÔØ´ÎÊý: 36)
) g- d5 I2 w( ~/ S) q gGMO Approval
0 ?( c- D ^( P0 z. n. k
% B6 u9 u: t6 Z' G0 A2 k; I _site_lis.gif (14.48 KB, ÏÂÔØ´ÎÊý: 16); z3 D* m1 X3 I4 S% `
Canadian Licence, J# O' w. A7 o& |) f# P4 i
- K4 D1 p# H) ~
|
|